Form 4: XTNT CEO's Tax Withholding on RSU Vesting
Insider Transaction Report
Xtant Medical Holdings, Inc. CEO Sean E. Browne reported the withholding of 10,605 common shares for tax obligations related to restricted stock unit vesting.
Summary
- Sean E. Browne, President and CEO, and a Director of Xtant Medical Holdings, Inc. (XTNT), reported a transaction on August 15, 2025.
- 10,605 shares of common stock were disposed of at a price of $0.63 per share.
- These shares were withheld by Xtant Medical Holdings, Inc. to cover tax withholding obligations upon the vesting and settlement of restricted stock unit awards.
- Following this transaction, Sean E. Browne beneficially owns 2,180,337 shares of common stock.
- This total includes 818,740 shares issuable upon future vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the 2023 Equity Incentive Plan, contingent on continued employment.
Sentiment
Score: 5
Explanation: Neutral. This Form 4 reports a routine, expected transaction related to executive compensation and tax obligations, with no direct positive or negative implications for the company's operational or financial performance.
Future Outlook
NA
Industry Context
This filing is a routine insider transaction report and does not provide information related to broader industry trends or competitor activities.
Stakeholder Impact
- Minimal direct impact on shareholders as this is a routine tax-related transaction for executive compensation.
- No direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 08/15/2025 | Date of transaction where shares were withheld for tax obligations. |
| 08/19/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 filing details a routine, non-discretionary transaction where shares were withheld to cover tax obligations upon the vesting of restricted stock units for the CEO. Such transactions are common and expected as part of executive compensation plans and do not reflect a change in the company's fundamental performance, strategic direction, or the insider's discretionary view of the stock. Therefore, it provides no new information to warrant a change in investment stance, suggesting a 'hold' recommendation based solely on this filing.
Keywords
Xtant Medical Holdings, XTNT, Sean E. Browne, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, CEO, Director, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.